Literature DB >> 19926817

Deletion of nuclear factor-E2-related factor-2 leads to rapid onset and progression of nutritional steatohepatitis in mice.

Hirokazu Sugimoto1, Kosuke Okada, Junichi Shoda, Eiji Warabi, Kazunori Ishige, Tetsuya Ueda, Keiko Taguchi, Toru Yanagawa, Akira Nakahara, Ichinosuke Hyodo, Tetsuro Ishii, Masayuki Yamamoto.   

Abstract

Oxidative stress is a critical mediator in liver injury of steatohepatitis. The transcription factor Nrf2 serves as a cellular stress sensor and is a key regulator for induction of hepatic detoxification and antioxidative stress systems. The involvement of Nrf2 in defense against the development of steatohepatitis remains unknown. We aimed to investigate the protective roles of Nrf2 in nutritional steatohepatitis using wild-type (WT) and Nrf2 gene-null (Nrf2-null) mice. WT and Nrf2-null mice were fed a methionine- and choline-deficient (MCD) diet for 3 and 6 wk, and the liver tissues were analyzed for pathology and for expression levels of detoxifying enzymes and antioxidative stress genes via the Nrf2 transcriptional pathway. In WT mice fed an MCD diet, Nrf2 was potently activated in the livers, and steatohepatitis did not develop over the observation periods. However, in Nrf2-null mice fed an MCD diet, the pathological state of the steatohepatitis was aggravated in terms of fatty changes, inflammation, fibrosis, and iron accumulation. In the livers of the Nrf2-null mice, oxidative stress was significantly increased compared with that of WT mice based on the increased levels of 4-hydroxy-2-nonenal and malondialdehyde. This change was associated with the decreased levels of glutathione, detoxifying enzymes, catalase, and superoxide dismutase activity. Correlating well with the liver pathology, the mRNA levels of factors involved in fatty acid metabolism, inflammatory cytokines, and fibrogenesis-related genes were significantly increased in the livers of the Nrf2-null mice. These findings demonstrate that Nrf2 deletion in mice leads to rapid onset and progression of nutritional steatohepatitis induced by an MCD diet. Activation of Nrf2 could be a promising target toward developing new options for prevention and treatment of steatohepatitis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19926817     DOI: 10.1152/ajpgi.00296.2009

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  60 in total

1.  Rosiglitazone attenuates age- and diet-associated nonalcoholic steatohepatitis in male low-density lipoprotein receptor knockout mice.

Authors:  Anisha A Gupte; Joey Z Liu; Yuelan Ren; Laurie J Minze; Jessica R Wiles; Alan R Collins; Christopher J Lyon; Domenico Pratico; Milton J Finegold; Stephen T Wong; Paul Webb; John D Baxter; David D Moore; Willa A Hsueh
Journal:  Hepatology       Date:  2010-10-11       Impact factor: 17.425

2.  Nrf2 enhances cholangiocyte expansion in Pten-deficient livers.

Authors:  Keiko Taguchi; Ikuo Hirano; Tohru Itoh; Minoru Tanaka; Atsushi Miyajima; Akira Suzuki; Hozumi Motohashi; Masayuki Yamamoto
Journal:  Mol Cell Biol       Date:  2013-12-30       Impact factor: 4.272

3.  Enhanced expression of Nrf2 in mice attenuates the fatty liver produced by a methionine- and choline-deficient diet.

Authors:  Yu-Kun Jennifer Zhang; Ronnie L Yeager; Yuji Tanaka; Curtis D Klaassen
Journal:  Toxicol Appl Pharmacol       Date:  2010-03-27       Impact factor: 4.219

Review 4.  Nrf2: a potential target for new therapeutics in liver disease.

Authors:  A M Bataille; J E Manautou
Journal:  Clin Pharmacol Ther       Date:  2012-08-08       Impact factor: 6.875

5.  Glucocorticoid receptor signaling represses the antioxidant response by inhibiting histone acetylation mediated by the transcriptional activator NRF2.

Authors:  Md Morshedul Alam; Keito Okazaki; Linh Thi Thao Nguyen; Nao Ota; Hiroshi Kitamura; Shohei Murakami; Hiroki Shima; Kazuhiko Igarashi; Hiroki Sekine; Hozumi Motohashi
Journal:  J Biol Chem       Date:  2017-03-17       Impact factor: 5.157

6.  Nrf2 inhibits hepatic iron accumulation and counteracts oxidative stress-induced liver injury in nutritional steatohepatitis.

Authors:  Kosuke Okada; Eiji Warabi; Hirokazu Sugimoto; Masaki Horie; Katsutoshi Tokushige; Tetsuya Ueda; Nobuhiko Harada; Keiko Taguchi; Etsuko Hashimoto; Ken Itoh; Tetsuro Ishii; Hirotoshi Utsunomiya; Masayuki Yamamoto; Junichi Shoda
Journal:  J Gastroenterol       Date:  2012-02-28       Impact factor: 7.527

Review 7.  p62/SQSTM1-Dr. Jekyll and Mr. Hyde that prevents oxidative stress but promotes liver cancer.

Authors:  Koji Taniguchi; Shinichiro Yamachika; Feng He; Michael Karin
Journal:  FEBS Lett       Date:  2016-08-06       Impact factor: 4.124

Review 8.  Nature and Implications of Oxidative and Nitrosative Stresses in Autoimmune Hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2016-07-13       Impact factor: 3.199

9.  Proteomic analysis of Nrf2 deficient transgenic mice reveals cellular defence and lipid metabolism as primary Nrf2-dependent pathways in the liver.

Authors:  Neil R Kitteringham; Azman Abdullah; Joanne Walsh; Laura Randle; Rosalind E Jenkins; Rowena Sison; Christopher E P Goldring; Helen Powell; Christopher Sanderson; Samantha Williams; Larry Higgins; Masayuki Yamamoto; John Hayes; B Kevin Park
Journal:  J Proteomics       Date:  2010-04-24       Impact factor: 4.044

Review 10.  Nuclear factor (erythroid-derived 2)-like-2 factor (Nrf2), a key regulator of the antioxidant response to protect against atherosclerosis and nonalcoholic steatohepatitis.

Authors:  Anisha A Gupte; Christopher J Lyon; Willa A Hsueh
Journal:  Curr Diab Rep       Date:  2013-06       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.